By Counterforce Health Team in Taltz (ixekizumab) —

How to Get Taltz (ixekizumab) Covered by Cigna in New York: Prior Authorization, Appeals & Success Tips

Quick Answer: Taltz (ixekizumab) requires prior authorization from Cigna in New York and sits on Tier 4 as a specialty medication. Your fastest path to approval: (1) Have your doctor document failed conventional therapies like methotrexate, (2) submit Cigna's PA form with clinical notes showing disease severity, and (3) enroll through Accredo specialty pharmacy. If denied, you have 180 days for internal appeal, then 4 months for New York DFS external review. Start by calling your doctor's office to initiate the PA process today.

Table of Contents

Getting Taltz (ixekizumab) covered by Cigna in New York requires navigating prior authorization, specialty pharmacy enrollment, and potentially the appeals process. But with the right documentation and approach, many patients successfully obtain coverage for this IL-17A inhibitor used to treat moderate-to-severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and related conditions.

Plan Types & Coverage Differences

Your Cigna plan type affects how you access Taltz and specialty care:

HMO Plans:

  • Referral required from your primary care provider to see dermatology or rheumatology specialists
  • Must use in-network providers only (except emergencies)
  • Prior authorization handled through your PCP's coordination

PPO Plans:

  • No referral needed to see specialists directly
  • Can use out-of-network providers but at higher cost
  • More flexibility in choosing prescribing physicians

EPO Plans:

  • No referral required for specialist visits
  • Must stay in-network for coverage (like HMO)
  • Cannot use out-of-network providers except emergencies
Note: All plan types require the same prior authorization process for Taltz, but HMO members must ensure their PCP coordinates the specialty referral and PA submission.

Formulary Status & Tier Placement

Taltz (ixekizumab) appears on Tier 4 as a specialty medication in Cigna's 2024 commercial and Medicare formularies. This placement means:

Coverage Aspect Details
Formulary Tier Tier 4 (Specialty)
Prior Authorization Required for all indications
Step Therapy May apply (varies by plan)
Quantity Limits Possible restrictions on supply
Preferred Pharmacy Accredo (Express Scripts specialty)

Alternative Medications on similar tiers include Cosentyx (secukinumab), Skyrizi (risankizumab), Stelara (ustekinumab), and Tremfya (guselkumab). If Taltz is denied, your doctor may need to document why these alternatives aren't suitable.

Prior Authorization Requirements

Cigna requires specific clinical documentation for Taltz approval:

Required Documentation:

  • Age verification (≥6 years for plaque psoriasis)
  • Confirmed diagnosis with ICD-10 codes
  • Prior therapy failures or contraindications to conventional treatments:
    • For psoriasis: methotrexate, cyclosporine, acitretin, or PUVA
    • For arthritis: conventional DMARDs
    • For spondylitis: NSAIDs, sulfasalazine, or methotrexate
  • Disease severity measures using validated scales:
    • PASI scores for psoriasis
    • DAPSA/CPDAI for psoriatic arthritis
    • BASDAI/BASFI for ankylosing spondylitis
  • Clinical notes documenting symptom severity and functional impact

For Continuation Therapy:

Patients must demonstrate beneficial clinical response after at least 6 months of treatment, measured by:

  • Improvement in validated disease activity scores
  • Reduced pain, stiffness, or improved daily functioning
  • Objective measures like decreased inflammatory markers

Specialty Pharmacy Setup

Cigna routes Taltz through Accredo specialty pharmacy. Here's the enrollment process:

Provider Steps:

  1. Complete referral form through Accredo's provider portal
  2. Submit PA documentation simultaneously
  3. Respond promptly to any coverage questions

Patient Steps:

  1. Call Accredo at 877-826-7657 once notified of enrollment
  2. Confirm shipping address and insurance information
  3. Set up online account at Accredo.com or through myCigna portal
  4. Schedule delivery (typically ships within 1-2 weeks of approval)

Accredo provides injection training, refill reminders, and 24/7 pharmacist support at no extra charge.

Step-by-Step: Fastest Path to Approval

1. Gather Documentation (Patient & Provider)

Who: Patient coordinates with provider's office
What: Insurance cards, prior therapy records, recent lab results, disease severity assessments
Timeline: 1-2 days

2. Complete Prior Authorization

Who: Prescribing physician
What: Submit Cigna's Taltz PA form with clinical justification
How: Through Cigna provider portal or fax
Timeline: 5 business days for Cigna review

3. Enroll with Accredo

Who: Provider initiates, patient completes
What: Specialty pharmacy enrollment and account setup
Timeline: 1-2 days after PA approval

4. Schedule First Shipment

Who: Patient
What: Confirm delivery details and injection training
Timeline: Ships within 1-2 weeks

5. Monitor and Maintain

Who: Patient and provider
What: Track clinical response for continuation approvals
Timeline: Ongoing assessments every 6 months

Common Denial Reasons & Solutions

Denial Reason How to Fix Required Documentation
Insufficient prior therapy Document failed conventional treatments Medication history, dates, outcomes, side effects
Lack of disease severity Submit validated assessment scores PASI, DAPSA, BASDAI results with dates
Missing TB screening Complete required testing Chest X-ray, interferon-gamma release assay
Step therapy not met Request exception or try preferred agent Medical contraindications to step therapy drugs
Quantity limit exceeded Justify higher dose/frequency Clinical rationale for dosing regimen
From our advocates: We've seen many initial denials overturned when providers include a detailed timeline of prior treatments with specific dates, doses, and documented reasons for discontinuation. Don't just list medications tried—explain why each one failed and why Taltz is the most appropriate next step.

Appeals Process in New York

If Cigna denies your Taltz request, New York offers robust appeal rights:

Internal Appeal (Required First Step)

External Review Through New York DFS

Timeline Summary:

Denial → Internal Appeal (180 days) → External Review (4 months) → Final Decision

Tip: New York DFS has overturned Cigna denials for Taltz when medical necessity was properly documented. Include peer-reviewed studies and specialty society guidelines in your appeal.

Cost-Saving Options

Even with insurance coverage, Taltz can be expensive. Consider these assistance programs:

Manufacturer Support:

  • Lilly Cares Foundation for uninsured/underinsured patients
  • Taltz Savings Card for commercially insured patients
  • Patient assistance programs with income requirements

State Programs:

  • New York State of Health premium tax credits
  • Medicaid expansion coverage
  • Essential Plan for lower-income individuals

Pharmacy Benefits:

  • Accredo's patient assistance program coordination
  • 90-day supplies to reduce copay frequency
  • Generic alternatives when available

Counterforce Health helps patients navigate these complex coverage decisions by turning insurance denials into targeted, evidence-backed appeals. Our platform identifies denial reasons and drafts point-by-point rebuttals aligned to each plan's specific requirements, making the appeals process more manageable for both patients and providers.

FAQ

How long does Cigna prior authorization take for Taltz in New York? Cigna typically responds within 5 business days, but complex cases may take up to 14 days. Expedited reviews are available for urgent medical situations.

What if Taltz isn't on my Cigna formulary? You can request a formulary exception by documenting medical necessity and why formulary alternatives aren't appropriate. This requires additional clinical justification.

Can I get expedited appeals in New York? Yes, if your health is at serious risk, New York DFS offers expedited external appeals with decisions within 72 hours (24 hours for urgent drug denials).

Does step therapy apply if I tried medications outside New York? Yes, documented prior therapies from other states count toward step therapy requirements. Ensure your provider includes complete medication histories.

What counts as "failure" of prior therapy? Lack of efficacy after adequate trial duration, intolerable side effects, or contraindications. Document specific reasons with dates and clinical notes.

How do I find Cigna-covered dermatologists in New York? Use Cigna's online provider directory or call member services. For HMO plans, get referrals from your primary care provider first.

What if my appeal is denied at every level? After exhausting New York's external review, consider filing complaints with state regulators or seeking legal counsel for complex cases involving coverage violations.

Can my doctor request a peer-to-peer review? Yes, providers can request to speak directly with Cigna's medical directors during the PA or appeal process to discuss clinical rationale.

When navigating Cigna's coverage for Taltz in New York, success often comes down to thorough documentation and understanding the specific requirements. Counterforce Health's platform streamlines this process by analyzing denial letters and plan policies to create targeted appeals that address each payer's unique criteria.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider about treatment decisions and verify current coverage details with Cigna and New York state resources.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.